 Prospective comparison esophageal variceal sclerotherapy agents sodium tetradecyl sulfate versus sodium morrhuate prospective randomized study differences efficacy complication rate sclerosing agents sodium tetradecyl sulfate STD sodium morrhuate MOR patients acute index variceal STD MOR dextrose Overall mortality STD group MOR group NS Control acute bleeding STD patients MOR patients NS Overall obliteration STD group MOR group patients study months obliteration NS trend rebleeding STD group MOR group significant difference STD MOR patients regard transfusion requirements units/patient units/patient ulceration stricture formation results study STD MOR equivalent solutions bias use agent